Glaxosmithkline | GSK - Ebit

Prix De L'Action
54.44
Variation Quotidienne
-4.68 -7.92%
Mensuellement
-8.13%
Annuel
45.44%
Q2 Prévisions
53.52




Ebit Changement Date
AbbVie USD 5.81B 4.36B 2025-12
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Aurora Cannabis CAD -35.79M 8.96M 2025-12
Bausch Health Companies USD 719M 2M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Canopy Growth CAD -12.66M 1.64M 2025-12
Corcept Therapeutics USD 4.49M 5.73M 2025-12
Drreddys Laboratories INR 16.37B 3.5B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 2.3B 1.46B 2025-12
J&J USD 6.62B 1.51B 2026-03
Merck USD 6.24B 1.32B 2025-12
Novartis USD 4.06B 530M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Perrigo USD 84.4M 9M 2025-12
Pfizer USD 4.65B 71M 2025-12
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 82.49M 2.82M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Teva Pharmaceutical Industries USD 577M 491M 2025-12
Zoetis USD 835M 140M 2025-12